These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1749115)

  • 1. [Study on the assay of uremic protein-binding inhibitors: furan compound and hippuric acid].
    Tanaka Y
    Nihon Jinzo Gakkai Shi; 1991 Jul; 33(7):643-51. PubMed ID: 1749115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
    Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
    Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced blood levels of coagulation inhibitors in chronic hemodialysis compared with CAPD.
    Bertoli SV; di Belgiojoso GB; Trezzi M; Scorza D; Barone MT; Poggio M; Rossi E; Landriani N; Genderini A
    Adv Perit Dial; 1995; 11():127-30. PubMed ID: 8534685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of haemodialysis and continuous ambulatory peritoneal dialysis on the plasma clearance of an albumin-bound furan dicarboxylic acid.
    Costigan MG; Yaqoob M; Lindup WE
    Nephrol Dial Transplant; 1995; 10(5):648-52. PubMed ID: 7566577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells.
    Mettang T; Fritz P; Weber J; Machleidt C; Hübel E; Kuhlmann U
    Clin Nephrol; 1990 Sep; 34(3):136-41. PubMed ID: 1699691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of phospholipids asymmetry in red blood cells contributes to anemia in uremic patients.
    Kong QY; Wu X; Li J; Peng WX; Ye R; Lindholm B; Wang T
    Adv Perit Dial; 2001; 17():58-60. PubMed ID: 11510298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippuric acid and 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid in serum and urine. Analytical approaches and clinical relevance in kidney diseases.
    Liebich HM; Bubeck JI; Pickert A; Wahl G; Scheiter A
    J Chromatogr; 1990 Feb; 500():615-27. PubMed ID: 2329153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.
    Tsao YT; Hsu YJ; Chu NF; Lai CH; Chiu JS; Lin SH
    J Nephrol; 2008; 21(5):744-52. PubMed ID: 18949730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis.
    Shoji T; Nishizawa Y; Nishitani H; Yamakawa M; Morii H
    Clin Nephrol; 1992 Nov; 38(5):271-6. PubMed ID: 1451340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
    Alhamdani MS
    Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients--Italian initiative on uremic hyperhomocysteinemia (IIUH).
    Perna AF; Ingrosso D; Molino D; Galletti P; Montini G; Zacchello G; Bellantuono R; Caringella A; Fede C; Chimenz R; De Santo NG
    J Nephrol; 2003; 16(4):516-21. PubMed ID: 14696753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis.
    Nakatani T; Naganuma T; Masuda C; Uchida J; Sugimura T; Sugimura K
    Int J Mol Med; 2002 Oct; 10(4):457-61. PubMed ID: 12239593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma amino acids in dialyzed children: comparison of hemodialysis and continuous ambulatory peritoneal dialysis].
    Perfumo F; Verrina E; Romano C; Cerone R; Caruso U; Gusmano R
    Pediatr Med Chir; 1986; 8(3):341-5. PubMed ID: 3786196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What does circulating beta 2 microglobulin signify in uremic patients on maintenance dialysis?].
    Assounga A; Canaud B; Flavier JL; Slingeneyer A; Robinet-Lévy M; Aznar R; Mion C
    Nephrologie; 1987; 8(6):301-6. PubMed ID: 3330579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis.
    Deltombe O; Van Biesen W; Glorieux G; Massy Z; Dhondt A; Eloot S
    Toxins (Basel); 2015 Sep; 7(10):3933-46. PubMed ID: 26426048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of immunophenotypic abnormalities in cellular immunity of uremic patients undergoing either hemodialysis or continuous ambulatory peritoneal dialysis.
    Griveas I; Visvardis G; Fleva A; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Ginikopoulou E; Meimaridou D; Paulitou A; Sakellariou G
    Ren Fail; 2005; 27(3):279-82. PubMed ID: 15957543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.